Logo image of COSM

COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

NASDAQ:COSM - Nasdaq - US2214133058 - Common Stock - Currency: USD

0.4635  +0.04 (+9.21%)

After market: 0.4491 -0.01 (-3.11%)

Fundamental Rating

2

Taking everything into account, COSM scores 2 out of 10 in our fundamental rating. COSM was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of COSM have multiple concerns. While showing a medium growth rate, COSM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
In the past 5 years COSM reported 4 times negative net income.
COSM had a negative operating cash flow in each of the past 5 years.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

COSM has a worse Return On Assets (-52.41%) than 89.22% of its industry peers.
COSM's Return On Equity of -96.67% is on the low side compared to the rest of the industry. COSM is outperformed by 77.45% of its industry peers.
Industry RankSector Rank
ROA -52.41%
ROE -96.67%
ROIC N/A
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

With a Gross Margin value of 8.10%, COSM is not doing good in the industry: 78.43% of the companies in the same industry are doing better.
COSM's Gross Margin has improved in the last couple of years.
COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COSM has more shares outstanding
The number of shares outstanding for COSM has been increased compared to 5 years ago.
Compared to 1 year ago, COSM has a worse debt to assets ratio.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

COSM has an Altman-Z score of -1.99. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COSM (-1.99) is worse than 84.31% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that COSM is not too dependend on debt financing.
COSM's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. COSM outperforms 68.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -1.99
ROIC/WACCN/A
WACC5.53%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

COSM has a Current Ratio of 1.44. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
COSM has a Current ratio (1.44) which is comparable to the rest of the industry.
A Quick Ratio of 1.24 indicates that COSM should not have too much problems paying its short term obligations.
The Quick ratio of COSM (1.24) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.24
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.83% over the past year.
Looking at the last year, COSM shows a quite strong growth in Revenue. The Revenue has grown by 13.03% in the last year.
COSM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.56% yearly.
EPS 1Y (TTM)71.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.18%
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%

3.2 Future

The Earnings Per Share is expected to grow by 41.97% on average over the next years. This is a very strong growth
COSM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.46% yearly.
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 45.44 indicates a quite expensive valuation of COSM.
COSM's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.77. COSM is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 45.44
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as COSM's earnings are expected to grow with 41.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.97%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COSM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSMOS HEALTH INC

NASDAQ:COSM (5/1/2025, 7:27:35 PM)

After market: 0.4491 -0.01 (-3.11%)

0.4635

+0.04 (+9.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)05-14 2025-05-14
Inst Owners6.97%
Inst Owner Change0%
Ins Owners19.11%
Ins Owner Change22.1%
Market Cap12.64M
Analysts82.86
Price Target3.06 (560.19%)
Short Float %2.49%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.06%
Min EPS beat(2)-301.07%
Max EPS beat(2)-5.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.09%
Min Revenue beat(2)-15.09%
Max Revenue beat(2)-13.09%
Revenue beat(4)1
Avg Revenue beat(4)-4.24%
Min Revenue beat(4)-15.09%
Max Revenue beat(4)12.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.18%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.44
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-2.23
EYN/A
EPS(NY)0.01
Fwd EY2.2%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS2.05
BVpS1.28
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.41%
ROE -96.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.1%
FCFM N/A
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 363.85%
Cap/Sales 6.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.24
Altman-Z -1.99
F-Score5
WACC5.53%
ROIC/WACCN/A
Cap/Depr(3y)618.48%
Cap/Depr(5y)438.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.18%
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.94%
OCF growth 3YN/A
OCF growth 5YN/A